biotech / news / / Devdiscourse
The initiative seeks to bring U.S. drug costs in line with other wealthy countries.
President Trump secured agreements with nine major drug companies to cut Medicaid and cash payer prices.
KEY POINTS
- Merck, Novartis, and GSK will reduce prices for a broad list of drugs under the deal.
- The agreements include significant discounts on medicines like Merck's Januvia and possible future drugs.
- The deals require increased U.S. manufacturing investment and faster FDA approvals for participating companies.
COMPANIES
Summarized by Newsio from Devdiscourse. How we summarize →